Times of IndiaExperimental drug prevents influenza deathsTimes of IndiaThe drug Eritoran has shown promise in treating influenza, preventing lung injury and death from the virus in preclinical studies, reported Science Daily, citing an University of Ma…
Study shows how grapes reduce heart failure – FreshPlaza – FreshPlaza
Study shows how grapes reduce heart failure – FreshPlazaFreshPlazaA study appearing in the Journal of Nutritional Biochemistry demonstrates that grapes are able to reduce heart failure associated with chronic high blood pressure (hypertension) by incre…
Sanofi lets go of rights to Regeneron's antibodies in ophthalmology – FierceBiotech
 iStockAnalyst |
Sanofi lets go of rights to Regeneron’s antibodies in ophthalmology
FierceBiotech The deal amends the collaboration between Sanofi and Regeneron for the antibodies that target receptors for platelet-derived growth factor (PDGF) and the angiopoietin2 (ANG2) receptor and ligand for eye ailments. Regeneron has agreed to pay Sanofi $10 … Regeneron Gains Full Rights to Ophthalmology Antibodies from Sanofi in $65M+ …Genetic Engineering News Regeneron Acquires Rights to Two Families of Novel AntibodiesBenzinga UPDATE 1-Regeneron raises 2013 Eylea sales view, profit beats StreetReuters UK RTT News –iStockAnalyst (press release) –Reuters all 23 news articles » |
Two Shaker Heights High seniors chosen as Gates scholars – Plain Dealer
Two Shaker Heights High seniors chosen as Gates scholarsPlain DealerShe has volunteered at the MCRD School for the Mentally Challenged in Kerala, India, and with the Friendship in Teams Foundation (FIT). She also plays varsity field hockey. Liz will at…
Legendary heavy metal guitarist Slayer 's Jeff Hanneman dies of liver failure – Daily News & Analysis
 Daily News & Analysis |
Legendary heavy metal guitarist Slayer ‘s Jeff Hanneman dies of liver failure
Daily News & Analysis US guitarist Jeff Hanneman, a co-founder of the seminal heavy metal band Slayer, died in Southern California on Thursday, the band said in a statement posted on their website. He was 49. “Hanneman was in an area hospital when he suffered liver failure … Slayer guitarist Jeff Hanneman dies at 49Yahoo! India News |
Coronary artery calcium buildup ups heart attack risk – Times of India
Times of IndiaCoronary artery calcium buildup ups heart attack riskTimes of IndiaThe study, conducted at Los Angeles Biomedical Research Institute (LA BioMed) and five other sites, suggests more frequent monitoring of patients with coronary artery calc…
Regeneron Acquires Rights to Two Families of Novel Antibodies – Benzinga
|
Regeneron Acquires Rights to Two Families of Novel Antibodies
Benzinga Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron’s … |
How grapes help reduce heart failure associated with hypertension – Daily News & Analysis
 Daily News & Analysis |
How grapes help reduce heart failure associated with hypertension
Daily News & Analysis An estimated 1 billion people worldwide have hypertension, which increases the risk of heart failure by 2 to 3-fold. Heart failure resulting from chronic hypertension can result in an enlarged heart muscle that becomes thick and rigid (fibrosis), and … Grapes Reduce Chances of Heart Failure in People with Hypertension, New …Sawfnews.com One fruit you need if you have high blood pressure – EmaxhealtheMaxHealth |
Slayer guitarist Jeff Hanneman dies of liver failure aged 49 – Metro
Slayer guitarist Jeff Hanneman dies of liver failure aged 49MetroThe band broke the news to fans on their Facebook page, saying that Hanneman had passed away in a California hospital after suffering liver failure. He had been battling the flesh-eating …
HKU discovers a novel cellular therapy for bone marrow transplantation related … – India Education Diary
 India Education Diary |
HKU discovers a novel cellular therapy for bone marrow transplantation related …
India Education Diary Hong Kong: The University of Hong Kong discovers a novel cellular therapy for bone marrow transplantation (BMT) related complications, such as graft-versus-host disease (GVHD). Researchers successfully induce “antigen-specific CD8+ regulatory T cells” … |